BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8759731)

  • 1. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.
    Strobl H; Riedl E; Scheinecker C; Bello-Fernandez C; Pickl WF; Rappersberger K; Majdic O; Knapp W
    J Immunol; 1996 Aug; 157(4):1499-507. PubMed ID: 8759731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B; Camus S; Yagello M; Gluckman JC
    Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis.
    Riedl E; Strobl H; Majdic O; Knapp W
    J Immunol; 1997 Feb; 158(4):1591-7. PubMed ID: 9029094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.
    Jaksits S; Kriehuber E; Charbonnier AS; Rappersberger K; Stingl G; Maurer D
    J Immunol; 1999 Nov; 163(9):4869-77. PubMed ID: 10528188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow.
    Yamaguchi Y; Tsumura H; Miwa M; Inaba K
    Stem Cells; 1997; 15(2):144-53. PubMed ID: 9090791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells.
    Rosenzwajg M; Camus S; Guigon M; Gluckman JC
    Exp Hematol; 1998 Jan; 26(1):63-72. PubMed ID: 9430515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transforming growth factor-beta 1 inhibits the generation of dendritic cells from murine hematopoietic progenitor cells in vitro].
    Zhang Y; Chen P; Zhang Y
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):178-80. PubMed ID: 11601034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.
    Sato K; Nagayama H; Takahashi TA
    Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.
    Markowicz S; Niedzielska J; Kruszewski M; Ołdak T; Gajkowska A; Machaj EK; Skurzak H; Pojda Z
    Acta Biochim Pol; 2006; 53(1):203-12. PubMed ID: 16404477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages.
    Santiago-Schwarz F; Belilos E; Diamond B; Carsons SE
    J Leukoc Biol; 1992 Sep; 52(3):274-81. PubMed ID: 1387891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
    Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
    Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model.
    St Louis DC; Woodcock JB; Franzoso G; Blair PJ; Carlson LM; Murillo M; Wells MR; Williams AJ; Smoot DS; Kaushal S; Grimes JL; Harlan DM; Chute JP; June CH; Siebenlist U; Lee KP
    J Immunol; 1999 Mar; 162(6):3237-48. PubMed ID: 10092775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
    Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.